Atom Investors’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Atom Investors’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-47,401	Closed	-$583K	–	335
2022 Q4	$583K	Buy	+47,401	New	+$1.13M	0.29%	77

Atom Investors's CINC Position: Q1 2023 in Review

Atom Investors sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 47,401 shares — an estimated $583K sold.

Atom Investors first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $583K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Atom Investors reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Atom Investors sold 47,401 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $583K.
Atom Investors first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Atom Investors's CinCor Pharma, Inc. Common Stock position peaked at $583K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Atom Investors's 13F filing for Q1 2023, filed 15 May 2023.